-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Regenerex Pharma, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2017 to Q2 2023.
- Regenerex Pharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2023 was -$3.63K.
- Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$6.3K, a 351% decline from 2022.
- Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$1.4K, a 83.7% increase from 2021.
- Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$8.6K.